With the Russian invasion stalled and with a forceful counter-attack by Ukrainian armed forces, many observers caution that the Kremlin might be considering a show of force much as the U.S. did in the atomic bombings of Hiroshima and Nagasaki (The Cancer Letter, Feb. 25, March 4, March 11, 2022).
As a global cancer society, ASCO represents oncology professionals in Ukraine and its neighboring countries, including Poland, Romania, Moldova, Slovakia, and Hungary.
As we enter week three of the Russian invasion of Ukraine, events continue to spiral out of control.
On Feb. 23, two exciting cancer initiatives converged in San Antonio, Texas: the Biden Administration’s Cancer Moonshot, and the third Advancing the Science of Cancer in Latinos biennial conference.
Ukraine has a special place in my heart, in my career, and in my life. A Ukrainian breast cancer project first introduced me to the field of global oncology, along with experience of seeing first-hand the challenges (and rewards) of providing cancer care and conducting cancer research in a setting of constrained resources. From my […]
In last week’s issue of The Cancer Letter, I discussed potential nuclear dangers resulting from Russia’s invasion of Ukraine (The Cancer Letter, Feb. 25, 2022). Unfortunately, several events I predicted might happen have occurred.
It was awe-inspiring to see how quickly the world’s science came together to address the COVID-19 pandemic—and much was learned. Academic institutions, big pharma, government, and foundations stepped up to do everything possible in an unprecedented way. Two years later, the results are evident as life is returning to normal.
The images from Ukraine are beyond endurance. There is nothing to say about the ethics of this conflict. A fascist autocrat who leads a confederacy of kleptocrats decides to invade a neighboring state under a KGB-honed delusion that has been out of date since the 1990s so that his nation will be “stronger” by reattaching itself to a the blasted remains of a cultural treasure.
No modern war has been fought on the territory of a country with nuclear power facilities.
On behalf of the millions of Americans with cancer, whose very lives depend on our nation’s investment in oncology research, we ask that you join us now in urging congressional lawmakers to do the right thing: pass robust funding for the National Institutes of Health and the National Cancer Institute.
